MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,251.00
+27.00 (2.21%)
Last updated: Jul 21, 2026, 2:01 PM KST

MYUNGMOON Pharm co.,Ltd Revenue

MYUNGMOON Pharm co.,Ltd had revenue of 48.00B KRW in the quarter ending March 31, 2026, with 4.63% growth. This brings the company's revenue in the last twelve months to 197.37B, up 4.94% year-over-year. In the year 2025, MYUNGMOON Pharm co.,Ltd had annual revenue of 195.25B with 4.72% growth.

Revenue (ttm)
197.37B
Revenue Growth
+4.94%
P/S Ratio
0.21
Revenue / Employee
678.25M
Employees
291
Market Cap
42.02B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025195.25B8.80B4.72%
Dec 31, 2024186.44B16.88B9.95%
Dec 31, 2023169.57B17.43B11.46%
Dec 31, 2022152.13B14.38B10.43%
Dec 31, 2021137.76B9.91B7.75%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jeil Pharma Holdings625.97B
Ildong Holdings598.69B
HANDOK550.69B
Kukje Pharma177.97B
CKD Bio159.93B
Yuyu Pharma143.52B
CMG Pharmaceutical110.12B
Dong Sung Bio Pharm.Co.,Ltd.78.44B
Revenue Rankings